Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketotifen + famotidine for facial melasma
RBR-7g4gp4Not yet recruiting
- Sponsor
- UNESP Botucatu Medical School
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in melasma comparing Ketotifen + famotidine with Placebo (2 arms). Planned start Mar 2020; status: not yet recruiting.
02
Drugs
ketotifenfamotidine
03
Conditions
melasma
Beyond the preview
Go deeper on RBR-7g4gp4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7g4gp4.